title: Bioanalysis-related highlights from the 2011 AAPS National Biotechnology Conference.
abstract: The American Association of Pharmaceutical Scientists is a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to drug development. The annual National Biotechnology Conference, conducted and organized by the American Association of Pharmaceutical Scientists, is a forum dedicated to advancements in science and technology related to discovery, development and manufacture of medical biotechnology products. The 2011 National Biotechnology Conference meeting convened in San Francisco, CA, USA on 16-18 May. Over 300 abstracts were submitted and approximately 50 sessions examined topics pertaining to advances in drug development, emerging analytical technologies, bioanalysis-related issues, biosimilar therapies, updates on global regulatory documents and expectations, and other topics. The focus of this article is to highlight key developments relevant to immunogenicity and pharmacokinetic drug concentration bioanalysis.
authors: Centocor, Research & Development, Inc., Johnson & Johnson, Research & Development, LLC, USA. rcrisino@its.jnj.com
authors: Rebecca M
authors: RM
authors: Crisino
authors: Beatriz
authors: B
authors: Dulanto
mesh_terms: D015415:Biomarkers / Q000097:blood; D001709:Biotechnology / Q000379:methods*; D019411:Clinical Laboratory Techniques / Q000379:methods*; D006801:Humans; D007118:Immunoassay / Q000379:methods; D004364:Pharmaceutical Preparations / Q000032:analysis* / Q000097:blood / Q000378:metabolism; D010599:Pharmacokinetics
chemical_list: D015415:Biomarkers; D004364:Pharmaceutical Preparations